Publication | Closed Access

Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions

Drug SafetyAdverse Drug ReactionsMedicineAdverse Drug ReactionPatient SafetyWho DatabasePharmacovigilancePharmacotherapyPharmacologyPharmacological IssueComparative Safety ProfilesSide Effect